Evonik Industries Ag Stock Current Valuation

EVKIF Stock  USD 18.25  0.35  1.96%   
Valuation analysis of Evonik Industries helps investors to measure Evonik Industries' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
18.25
Please note that Evonik Industries' price fluctuation is not too volatile at this time. Calculation of the real value of Evonik Industries is based on 3 months time horizon. Increasing Evonik Industries' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Evonik pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Evonik Industries AG. Since Evonik Industries is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Evonik Pink Sheet. However, Evonik Industries' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  18.25 Real  16.34 Hype  18.25 Naive  19.29
The real value of Evonik Pink Sheet, also known as its intrinsic value, is the underlying worth of Evonik Industries Company, which is reflected in its stock price. It is based on Evonik Industries' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Evonik Industries' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
16.34
Real Value
18.63
Upside
Estimating the potential upside or downside of Evonik Industries AG helps investors to forecast how Evonik pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Evonik Industries more accurately as focusing exclusively on Evonik Industries' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
17.5819.6021.62
Details
Hype
Prediction
LowEstimatedHigh
15.9618.2520.54
Details
Naive
Forecast
LowNext ValueHigh
17.0019.2921.58
Details

Evonik Industries AG Company Current Valuation Analysis

Evonik Industries' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Evonik Industries Current Valuation

    
  11.78 B  
Most of Evonik Industries' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evonik Industries AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Evonik Industries AG has a Current Valuation of 11.78 B. This is 3.24% higher than that of the Basic Materials sector and 61.76% lower than that of the Specialty Chemicals industry. The current valuation for all United States stocks is 29.14% higher than that of the company.

Evonik Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Evonik Industries' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Evonik Industries could also be used in its relative valuation, which is a method of valuing Evonik Industries by comparing valuation metrics of similar companies.
Evonik Industries is currently under evaluation in current valuation category among its peers.

Evonik Fundamentals

About Evonik Industries Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Evonik Industries AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evonik Industries using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evonik Industries AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Evonik Pink Sheet

Evonik Industries financial ratios help investors to determine whether Evonik Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Evonik with respect to the benefits of owning Evonik Industries security.